Llorca, P., Miadi-Fargier, H., Lançon, C., Jasso Mosqueda, G., Casadebaig, F. and Philippe, A. (2005) Cost-Effectiveness Analysis of Management Strategies for Schizophrenic Patients: Place of an Atypical Antipsychotic in Prolonged-Release Injectable Form. The Encephalon, 31, 235-246.
https://doi.org/10.1016/S0013-7006(05)82390-5

has been cited by the following article:

• TITLE: The Use of Atypical Neuroleptics in Drugs Management in Fann’s Psychiatry Department

  AUTHORS: Ndèye Dialé Ndiaye Ndongo, Lamine Fall, Aida Sylla, Sénéba Cissé, Mamadou Habib Thiam

  KEYWORDS: Atypical Neuroleptics, Classic Neuroleptics, Psychiatry, Senegal

  JOURNAL NAME: Open Journal of Psychiatry, Vol.11 No.1, January 12, 2021

  ABSTRACT: Background and Objectives: Neuroleptics have revolutionized pharmacological management in psychiatry. The advent of atypical neuroleptics constitutes a major turning point in this therapeutic challenge. The objective of our study was to determine the prescription of these atypical neuroleptics in Fann’s psychiatry department. Methodology: It was a descriptive retrospective cross-sectional study that involved 223 patients hospitalized in the psychiatry department of Fann Hospital during the period from January 2015 to December 2017. Results: Our study shows a majority prescription of classic neuroleptics in combination Haloperidol-Chlorpromazine 53% and 14% in monotherapy and a prescription of atypical neuroleptics at 4%. They are prescribed in combination with the classics at 4%. Conclusion: These results show a still low prescription of atypical neuroleptics which raises questions about the availability and affordability of such drugs, but also about prescription habits in the context of developing country.